A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in subjects with Acute Traumatic Cervical Spinal Cord Injury
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
Christopher Kleck
Study ID
Protocol Number: 21-3382
More information available at ClinicalTrials.gov: NCT04683848
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers